April 28, 2014
A drug that packs a punch: new compound works better against resistant HIV
Bond LSC researcher Stefan Sarafianos stands in the LSC atrium. The virologist is an associate professor of molecular microbiology and immunology and Chancellor’s Chair of Excellence in Molecular Virology with appointments in MU’s School of Medicine and the Department of Biochemistry. Resistance is the price of success when it comes to treating HIV. Virologists at the Bond Life Sciences Center are helping to test the next generation of anti-AIDS medication to quell that resistance. Stefan Sarafianos’ lab recently proved that EFdA, a compound that stops HIV from spreading, is 70 times more potent against some HIV…
